B
PFE icon

Birchbrook’s Pfizer PFE Stock Holding History

Birchbrook’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1K Hold
2,121
– – 0.02% 132
2026
Q1 		$59.6K Sell
2,121
-285
-12% -$7.59K 0.03% 120
2025
Q4 		$59.9K Buy
2,406
+285
+13% +$7.19K 0.03% 117
2025
Q3 		$54K Sell
2,121
-670
-24% -$16.5K 0.03% 122
2025
Q2 		$67.7K Hold
2,791
– – 0.04% 114
2025
Q1 		$70.7K Sell
2,791
-644
-19% -$16.9K 0.04% 105
2024
Q4 		$91.1K Hold
3,435
– – 0.05% 94
2024
Q3 		$99.4K Sell
3,435
-300
-8% -$8.75K 0.06% 92
2024
Q2 		$105K Hold
3,735
– – 0.06% 93
2024
Q1 		$104K Hold
3,735
– – 0.06% 93
2023
Q4 		$108K Buy
+3,735
New +$113K 0.07% 89

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Birchbrook's PFE Position: Q2 2026 in Review

Birchbrook held its Pfizer (PFE) position steady in Q2 2026 at 2,121 shares worth $51.1K. The position accounts for 0.02% of the portfolio, ranked #132.

Birchbrook first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $108K in Q4 2023. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Birchbrook held 2,121 shares of Pfizer worth $51.1K as of Q2 2026.
  • Birchbrook left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.02% of Birchbrook's portfolio in Q2 2026, its #132 holding.
  • Birchbrook first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Birchbrook's Pfizer position peaked at $108K in Q4 2023.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.